The United Kingdom is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the well-established use of psilocybin and LSD, investigators and explorers are increasingly focused on less-charted territories, particularly the copyright compound and the nascent cannabinoid, cannabigerol. This burgeoning movement encompass